G-CSF-induced remission in two cases of acute myeloid leukemia

Leukemia Research

Volumn 32, Issue 7, 2008, Pages 1148-1152

  Benz, Rudolf ^a   Goede, Jeroen S ^a   Parlier, Valérie ^b   Mühlematter, Dominique ^b   Jotterand, Martine ^b   Fehr, Jörg ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Acute myeloid leukemia (AML); Filgrastim; G CSF; Remission

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; BLOOD CELL COUNT; BLOOD TRANSFUSION; CANCER REGRESSION; CASE REPORT; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; COMORBIDITY; DISEASE COURSE; DRUG DOSE REDUCTION; HUMAN; MALE; NEUTROPENIA; PRIORITY JOURNAL; SEPTICEMIA;

AGED; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; REMISSION INDUCTION;

EID: 41949128632     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.11.020     Document Type: Article

References (9)

1. Sachs L. Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature 274 (1978) 535-538
2. Bassan R., Rambaldi A., Amaru R., Motta T., and Barbui T. Unexpected remission of acute myeloid leukemia after GM-CSF. Br J Hematol 87 (1994) 835-837
3. Zomas A., Stefanoudaki-Safianatou K., Fisfis M., and Anagnostopoulos N.I. Dose dependent long-term in vivo remission of AML1/ETO positive acute myeloid leukemia with G-CSF. Hematology 9 2 (2004) 107-111
4. Ferrara F., Di Noto R., Viola A., Russo C., Boccuni P., Costantini S., et al. Complete remission in acute myeloid leukaemia with t(8;21) following treatment with G-CSF: flow cytometric analysis of in vivo and in vitro effects on cell maturation. Br J Haematol 106 (1999) 520-523
5. Takamatsu Y., Miyamoto T., Iwasaki H., Makino S., and Tamura K. Remission induction by granulocyte colony-stimulating factor in hypoplastic acute myelogenous leukemia complicated by infection. Acta Haematol 99 (1998) 224-230
6. Ayton P.M., and Cleary M.L. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 20 (2001) 5695-5707
7. Inukai T., Sugita K., Iijima K., Goi K., Tezuka T., Kojika S., et al. Leukemic cells with 11q23 translocations express granulocyte colony-stimulating factor (G-CSF) receptor and their proliferation is stimulated with G-CSF. Leukemia 12 (1998) 382-389
8. Appelbaum F.R., Gundacker H., Head D.R., Slovak M.L., Willman C.L., Godwin J.E., et al. Age and acute myeloid leukemia. Blood 107 (2006) 3481-3485
9. Farag S.S., Archer K.J., Mrózek K., Ruppert A.S., Carroll A.J., Vardiman J.W., et al. Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461. Blood 108 (2006) 63-73